Publications by authors named "W Jiskoot"

Claim this Profile
Q
Quality (Attributes) over quantity: Minimal essential quality attributes for determining antibody stability in postproduction handling stability studies.
Roderick van den Berg, Renske Penning, Reza Nejadnik, Wim Jiskoot, Tim Menzen

J Pharm Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cationic pH-sensitive liposomes as tuberculosis subunit vaccine delivery systems: Effect of liposome composition on cellular innate immune responses.
M M Szachniewicz, K E van Meijgaarden, E Kavrik, W Jiskoot, J A Bouwstra

Int Immunopharmacol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Versatile, Low-Cost Modular Microfluidic System to Prepare Poly(Lactic-co-Glycolic Acid) Nanoparticles With Encapsulated Protein.
Malene Aaby Neustrup, Tom H M Ottenhoff, Wim Jiskoot, Joke A Bouwstra, Koen van der Maaden

Pharm Res· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrinsic immunogenicity of liposomes for tuberculosis vaccines: Effect of cationic lipid and cholesterol.
M M Szachniewicz, M A Neustrup, K E van Meijgaarden, W Jiskoot, J A Bouwstra

Eur J Pharm Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncovalent Conjugation of OVA323 to ELP Micelles Increases Immune Response.
Jolinde van Strien, Max Makurat, Ye Zeng, René Olsthoorn, Gregory F Schneider, Wim Jiskoot

Biomacromolecules· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis